Aline Marzano-Miranda , Jamil S. Oliveira , Marla P.C. Marcelino , Adalberto A. Pereira-Filho , João Victor N. Starlino , Gilmar R.F. Pascoal , Daniella C. Bartholomeu , Vanessa G. Fraga , Erika M. Braga
{"title":"高效液相色谱法纯化跨膜带3蛋白","authors":"Aline Marzano-Miranda , Jamil S. Oliveira , Marla P.C. Marcelino , Adalberto A. Pereira-Filho , João Victor N. Starlino , Gilmar R.F. Pascoal , Daniella C. Bartholomeu , Vanessa G. Fraga , Erika M. Braga","doi":"10.1016/j.jchromb.2025.124631","DOIUrl":null,"url":null,"abstract":"<div><div>Band 3 is the most abundant protein in the red blood cell membrane and has garnered increasing attention across various research fields. However, commercially available recombinant Band 3 is limited to its cytoplasmic domain, typically produced in <em>Escherichia coli</em>, rendering it unsuitable for studies involving the transmembrane region. Furthermore, the purification of Band 3 from red blood cells (RBC) presents challenges due to its strong interactions with membrane and cytoskeletal proteins, often necessitating immunoprecipitation as the primary method to obtain it in a soluble form. This study validates a chromatographic strategy for purifying Band 3 from erythrocyte membranes. Soluble ghosts were processed using reverse-phase chromatography followed by size-exclusion chromatography. Molecular weight validation was performed using polyacrylamide gels, and the presence of soluble Band 3 was confirmed through western blot analysis. This method leverages the physicochemical properties of proteins—specifically their hydrophobicity and size—to facilitate the cost-effective and efficient purification of Band 3.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1261 ","pages":"Article 124631"},"PeriodicalIF":2.8000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"High-performance liquid chromatography strategy for purifying the transmembrane band 3 protein\",\"authors\":\"Aline Marzano-Miranda , Jamil S. Oliveira , Marla P.C. Marcelino , Adalberto A. Pereira-Filho , João Victor N. Starlino , Gilmar R.F. Pascoal , Daniella C. Bartholomeu , Vanessa G. Fraga , Erika M. Braga\",\"doi\":\"10.1016/j.jchromb.2025.124631\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Band 3 is the most abundant protein in the red blood cell membrane and has garnered increasing attention across various research fields. However, commercially available recombinant Band 3 is limited to its cytoplasmic domain, typically produced in <em>Escherichia coli</em>, rendering it unsuitable for studies involving the transmembrane region. Furthermore, the purification of Band 3 from red blood cells (RBC) presents challenges due to its strong interactions with membrane and cytoskeletal proteins, often necessitating immunoprecipitation as the primary method to obtain it in a soluble form. This study validates a chromatographic strategy for purifying Band 3 from erythrocyte membranes. Soluble ghosts were processed using reverse-phase chromatography followed by size-exclusion chromatography. Molecular weight validation was performed using polyacrylamide gels, and the presence of soluble Band 3 was confirmed through western blot analysis. This method leverages the physicochemical properties of proteins—specifically their hydrophobicity and size—to facilitate the cost-effective and efficient purification of Band 3.</div></div>\",\"PeriodicalId\":348,\"journal\":{\"name\":\"Journal of Chromatography B\",\"volume\":\"1261 \",\"pages\":\"Article 124631\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-05-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Chromatography B\",\"FirstCategoryId\":\"1\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1570023225001850\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Chromatography B","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1570023225001850","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
High-performance liquid chromatography strategy for purifying the transmembrane band 3 protein
Band 3 is the most abundant protein in the red blood cell membrane and has garnered increasing attention across various research fields. However, commercially available recombinant Band 3 is limited to its cytoplasmic domain, typically produced in Escherichia coli, rendering it unsuitable for studies involving the transmembrane region. Furthermore, the purification of Band 3 from red blood cells (RBC) presents challenges due to its strong interactions with membrane and cytoskeletal proteins, often necessitating immunoprecipitation as the primary method to obtain it in a soluble form. This study validates a chromatographic strategy for purifying Band 3 from erythrocyte membranes. Soluble ghosts were processed using reverse-phase chromatography followed by size-exclusion chromatography. Molecular weight validation was performed using polyacrylamide gels, and the presence of soluble Band 3 was confirmed through western blot analysis. This method leverages the physicochemical properties of proteins—specifically their hydrophobicity and size—to facilitate the cost-effective and efficient purification of Band 3.
期刊介绍:
The Journal of Chromatography B publishes papers on developments in separation science relevant to biology and biomedical research including both fundamental advances and applications. Analytical techniques which may be considered include the various facets of chromatography, electrophoresis and related methods, affinity and immunoaffinity-based methodologies, hyphenated and other multi-dimensional techniques, and microanalytical approaches. The journal also considers articles reporting developments in sample preparation, detection techniques including mass spectrometry, and data handling and analysis.
Developments related to preparative separations for the isolation and purification of components of biological systems may be published, including chromatographic and electrophoretic methods, affinity separations, field flow fractionation and other preparative approaches.
Applications to the analysis of biological systems and samples will be considered when the analytical science contains a significant element of novelty, e.g. a new approach to the separation of a compound, novel combination of analytical techniques, or significantly improved analytical performance.